Appropriate Duration of Driving Restrictions After Inappropriate Therapy From Implantable Cardiac Shock Devices-Reference-Cited by-同舟云学术

Appropriate Duration of Driving Restrictions After Inappropriate Therapy From Implantable Cardiac Shock Devices

Published:2014 Issue:8 Volume:78 Page:1989-1991
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Noda Takashi¹,Kurita Takashi²,Nitta Takashi³,Abe Haruhiko⁴,Watanabe Shigeyuki⁵,Furushima Hiroshi⁶,Matsumoto Naoki⁷,Toyoshima Takeshi⁸,Shimizu Akihiko⁹,Mitamura Hideo¹⁰,Ohe Tohru¹¹,Aizawa Yoshifusa¹²

Affiliation:

1. Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center

2. Division of Cardiovascular Center, Department of Internal Medicine, Kinki University School of Medicine

3. Department of Cardiovascular Surgery, Nippon Medical School

4. Department of Heart Rhythm Management, University of Occupational and Environmental Health, Japan

5. Department of Cardiology, Tsukuba University Hospital Mito Medical Center

6. The First Department of Internal Medicine, Niigata University School of Medicine

7. Department of Pharmacology, St. Marianna University School of Medicine

8. Faculty of Health and Medical Care, Saitama Medical University

9. Faculty of Health Sciences, Yamaguchi University Graduate School of Medicine

10. Tachikawa Hospital

11. The Sakakibara Heart Institute of Okayama

12. Department of Research and Development, Tachikawa Medical Center

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/78/8/78_CJ-14-0589/_pdf

Reference14 articles.

1. 1. BardyGH,LeeKL,MarkDB,PooleJE,PackerDL,BoineauR, et al.Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.N Engl J Med2005;352:225–237.

2. 2. BristowMR,SaxonLA,BoehmerJ,KruegerS,KassDA,De MarcoT, et al.Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.N Engl J Med2004;350:2140–2150.

3. 3. MossAJ.What we have learned from the family of multicenter automatic defibrillator implantation trials.Circ J2010;74:1038–1041.

4. 4. MiyoshiT,KamiyaCA,KatsuragiS,UedaH,KobayashiY,HoriuchiC, et al.Safety and efficacy of implantable cardioverter-defibrillator during pregnancy and after delivery.Circ J2013;77:1166–1170.

5. 5. MomomuraS,TsutsuiH,SugawaraY,ItoM,MitsuhashiT,FukamizuS, et al; MOMIJI Study Investigators.Clinical efficacy of cardiac resynchronization therapy with an implantable defibrillator in a Japanese population: Results of the MIRACLE-ICD outcome measured in Japanese indication (MOMIJI) study.Circ J2012;76:1911–1919.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Electrical Storms Recur Over Time in Patients With Implantable Cardioverter Defibrillators　― Subanalysis of the Nippon Storm Study ―;Circulation Journal;2024-08-22

2. JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia;Journal of Arrhythmia;2024-06-12

3. Role of Implantable Cardioverter Defibrillators in Patients With Heart Failure and Nonischemic Cardiomyopathy in Japan　― Analysis From the Nippon Storm Study ―;Circulation Journal;2023-12-07

4. Two-Year Outcomes of Primary Prophylactic Use of Defibrillators for Ischemic and Non-Ischemic Cardiomyopathy　― Propensity Score-Matched Analysis From the Nippon Storm Study ―;Circulation Journal;2023-12-07

5. JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia;Circulation Journal;2023-09-11